Kathryn Zoon Net Worth & Insider Trades
Kathryn Zoon - Director, Emergent Biosolutions Inc
What is Kathryn Zoon's Net Worth?
The current estimated net worth of Emergent Biosolutions Inc's Director, Kathryn Zoon, is estimated to be about $1.93M . Kathryn Zoon owns about 49,971 units of Emergent Biosolutions Inc common stock. In the last 7 years at Emergent Biosolutions Inc, Kathryn Zoon has sold an estimated value of $1.85M worth.
What is Kathryn Zoon's Past Insider Trading?
Kathryn Zoon's largest sale order was 4,093 units , worth over $348.32K on May 27, 2020. In total, Kathryn Zoon has made about 23 transactions over 7 years of their time at Emergent Biosolutions Inc. Kathryn Zoon usually trades in May, with the busiest year in 2020. The most recent transaction was a sale order of 3,530 units , worth over $29.53K on July 24, 2023.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Kathryn Zoon
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
InsideArbitrage
What is Kathryn Zoon's' Mailing Address?
- Mailing address is 400 Professional Drive Suite 400 Gaithersburg MD 20879 MD
Emergent Biosolutions Inc Executive Compensation
Name |
Year
|
Salary
|
Stock Awards
|
Option Awards
|
Other Earnings Plans or Compensations
|
Other Compensation
|
Total
|
|---|---|---|---|---|---|---|---|
| Fuad El-Hibri | 2020 | $1,192,202 | $1,200,046 | $815,051 | - | $6,185 | $3,213,484 |
| Fuad El-Hibri | 2019 | $1,131,577 | $1,099,949 | $773,813 | - | $4,723 | $3,010,062 |
| Fuad El-Hibri | 2018 | $1,047,031 | $957,456 | $957,481 | - | $8,250 | $2,970,218 |
| Robert Kramer | 2020 | $893,860 | $2,050,007 | $1,392,416 | $1,225,020 | $8,675 | $5,569,978 |
| Robert Kramer | 2019 | $678,021 | $1,439,958 | $1,012,999 | $557,108 | $5,735 | $3,693,821 |
| Robert Kramer | 2018 | $549,047 | $649,930 | $649,980 | $538,807 | $8,983 | $2,396,747 |
| Richard Lindahl | 2020 | $549,390 | $749,998 | $509,425 | $462,012 | $10,475 | $2,281,300 |
| Richard Lindahl | 2019 | $514,826 | $619,984 | $436,154 | $297,429 | $9,104 | $1,877,497 |
| Richard Lindahl | 2018 | $365,393 | $557,438 | $351,101 | $330,007 | $8,514 | $1,612,453 |
| Adam Havey | 2020 | $546,507 | $700,047 | $475,413 | $445,204 | $8,357 | $2,175,528 |
| Adam Havey | 2019 | $484,120 | $619,984 | $436,154 | $279,579 | $25,530 | $1,845,367 |
| Adam Havey | 2018 | $480,728 | $499,974 | $359,784 | $310,212 | $8,383 | $1,659,081 |
| Atul Saran | 2020 | $528,803 | $700,047 | $475,413 | $445,204 | $9,565 | $2,159,032 |
| Atul Saran | 2019 | $503,774 | $619,984 | $436,154 | $293,567 | $9,500 | $1,862,979 |
| Atul Saran | 2018 | $488,730 | $527,475 | $379,572 | $293,567 | $8,683 | $1,698,027 |
| No matching records found | |||||||
Source: https://www.sec.gov/Archives/edgar/data/1367644/000136764421000061/ebsi2021asmproxystatement.htm
What are Emergent Biosolutions Inc's Past Insider Trades?
Emergent Biosolutions Inc's most recent insider trade came on July 24, 2023 by Kathryn Zoon who sold 3,530 units worth $29.53K . In the last 17 years, insiders at Emergent Biosolutions Inc have sold an estimated value of $238.51M and bought an estimated value of $38.64M worth of shares. Insider trading is most common in May, with the busiest year in 2007. The most active traders at the company are Fuad Elhibri, Director, Daniel Abdunnabi, CEO, and Robert Kramer, President and CEO .
Emergent BioSolutions Inc. Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||